Multiple sclerosis (MS) is just one example of the many complex autoimmune diseases that could benefit from our T-cell vaccination (TCV) technology. This revolutionary method has the potential not only to transform the treatment of autoimmune diseases, but also to offer solutions for certain types of cancer.
The concept of T Cell Vaccination (TCV)
At the heart of this technology lies immunization with attenuated auto-reactive T cells. These modified T cells have the ability to induce specific inhibition of autoimmune and, in some cases, tumor responses.
Customization and individualization
Each vaccine is tailor-made for each patient.
By harvesting the T cells responsible for the disease directly from the patient, we are able to create a vaccine that precisely targets the pathological mechanisms specific to each individual;
This makes this approach a truly individualized and customized solution.
Application to Various Diseases
Although TCV has been studied primarily in the context of MS, its scope extends to a wide range of diseases, including some forms of cancer.
T cells play a central role in regulating the immune response, which means their modulation can have an impact on a variety of medical conditions.
Versatile mechanism of action
Modified T cells are not limited to targeting autoimmune cells alone, they also have the potential to attack cancer cells. This versatility makes TCV a particularly promising option for a variety of patients suffering from conditions as diverse as MS, lupus and certain types of cancer.
Renewed hope
With over a decade of clinical use worldwide, TCV offers a new line of defense against debilitating and potentially fatal diseases. By addressing the underlying causes of these conditions, this method paves the way for more effective, longer-lasting and less invasive treatments.
T-Cells therapy, an individualized therapeutic approach
Our T-cell vaccines offer an individualized and versatile therapeutic approach that has the potential to redefine the treatment landscape for autoimmune diseases and certain cancers. Talk to your healthcare team to find out if this pioneering treatment option could be right for you.